Nra-amlodipine 5mg: Affected Lot May Contain Tablet(s) Of Metoprolol Succinate Prolonged–release 12.5 Mg Tablets

NRA-AMLODIPINE 5MG tablets are being recalled because some affected lots may contain tablets of a different medication—Metoprolol Succinate prolonged-release 12.5 mg—mixed in with the correct product. This recall affects NRA-AMLODIPINE 5MG distributed across Canada. The recall is classified as Class I, which indicates a serious safety concern.

Product
NRA-AMLODIPINE 5MG
Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2025-07-08
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/165a24dc-272f-4ac6-a041-7382b7faf687